Latanoprostene bunod Brand Name– VYZULTA
What is Latanoprostene bunod
Latanoprostene bunod is a prostaglandin analog indicated for the reduction of intraocular pressure in patients with open angle glaucoma or ocular hypertension.
The drug is administered topically once daily in the evening to affected eye(s); more frequent administration may reduce the drugs intraocular pressure lowering effect.
Prior to drug administration, inform patients of the potential for irreversible pigmentation (brown) of the iris.
Indications
- glaucoma
- ocular hypertension
For the reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension
Side Effects
- blurred vision
- conjunctival hyperemia
- foreign body sensation
- hypertrichosis
- iridal discoloration
- keratitis
- ocular irritation
- ocular pain
- skin hyperpigmentation
Monitoring Parameters
- intraocular pressure
- ophthalmologic exam
Contraindications
- aphakia
- breast-feeding
- children
- contact lenses
- infants
- iritis
- keratitis
- neonates
- ocular inflammation
- pregnancy
- uveitis
Interactions
There are no drug interactions associated with Latanoprostene bunod products.
